Mark Namchuk

3.0k total citations
29 papers, 1.7k citations indexed

About

Mark Namchuk is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Mark Namchuk has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Computational Theory and Mathematics. Recurrent topics in Mark Namchuk's work include Computational Drug Discovery Methods (5 papers), Enzyme Catalysis and Immobilization (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Mark Namchuk is often cited by papers focused on Computational Drug Discovery Methods (5 papers), Enzyme Catalysis and Immobilization (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Mark Namchuk collaborates with scholars based in United States, Canada and Ireland. Mark Namchuk's co-authors include W. Patrick Walters, Stephen G. Withers, Keisuke Kuida, John D. McCarter, Trevor Andrews, Adam Becalski, Ursula A. Germann, Pamella J. Ford, John Kyriakis and Thomas Force and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Circulation.

In The Last Decade

Mark Namchuk

28 papers receiving 1.7k citations

Peers

Countries citing papers authored by Mark Namchuk

Since Specialization

Citations

This map shows the geographic impact of Mark Namchuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Namchuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Namchuk more than expected).

Fields of papers citing papers by Mark Namchuk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Namchuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Namchuk. The network helps show where Mark Namchuk may publish in the future.

Co-authorship network of co-authors of Mark Namchuk

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Namchuk. A scholar is included among the top collaborators of Mark Namchuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Namchuk. Mark Namchuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of dimeric SARS-CoV-2 Mpro displays positive cooperativity and a mixture of covalent and non-covalent binding 2025 ·iScience ·Krishna Mohan Das, Jun Chen, Paul S. Charifson, Jeremy Green, (unknown), Sanjay C. Panchal, Fan Pu, Alla Korepanova, Abhinav Dubey, (unknown), (unknown), B. Nocek, L. Bigelow, Sarah H. Stubbs, Robert A. Davey, David A. DeGoey, Haribabu Arthanari, Mark Namchuk	0
2	Advancing New Chemical Modalities into Clinical Studies 2022 ·ACS Medicinal Chemistry Letters ·María‐Jesús Blanco, Kevin M. Gardinier, Mark Namchuk	32
3	A review of clinical efficacy data supporting emergency use authorization for COVID‐19 therapeutics and lessons for future pandemics 2022 ·Clinical and Translational Science ·(unknown), Lauren Kim, (unknown), (unknown), Mark Namchuk	5
4	In vivo Characterization of the Opioid Receptor–Binding Profiles of Samidorphan and Naltrexone in Rats: Comparisons at Clinically Relevant Concentrations 2022 ·Neuropsychiatric Disease and Treatment ·Laura A. Tan, (unknown), Lei Sun, (unknown), Ying Zhou, Mark Namchuk, (unknown)	5
5	Insulin and glucose metabolism with olanzapine and a combination of olanzapine and samidorphan: exploratory phase 1 results in healthy volunteers 2021 ·Neuropsychopharmacology ·Frederico G. S. Toledo, William Martin, Linda Morrow, Carine Beysen, Daiva Bajorunas, Ying Jiang, Bernard L. Silverman, David McDonnell, Mark Namchuk, John W. Newcomer, Christine Graham	8
6	184 Insulin Sensitivity and Glucose Metabolism of Olanzapine and Combination Olanzapine and Samidorphan: A Phase 1 Exploratory Study in Healthy Volunteers 2020 ·CNS Spectrums ·William Martin, Christine Graham, Linda Morrow, Carine Beysen, Frederico G. S. Toledo, Daiva Bajorunas, Ying Jiang, Bernard L. Silverman, David McDonnell, Mark Namchuk, John W. Newcomer	2
7	Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates 2019 ·Journal of Psychopharmacology ·(unknown), (unknown), Mark S. Todtenkopf, Reginald L. Dean, Daniel R. Deaver, Connie Sánchez, Mark Namchuk	27
8	Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and nonhuman primates 2019 ·European Neuropsychopharmacology ·(unknown), (unknown), Mark S. Todtenkopf, Reginald L. Dean, (unknown), Daniel R. Deaver, Connie Sánchez, Mark Namchuk	2
9	In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive Disorder 2018 ·Journal of Pharmacology and Experimental Therapeutics ·Jean M. Bidlack, Brian I. Knapp, Daniel R. Deaver, (unknown), Derrick R. Arnelle, (unknown), (unknown), Sokhom S. Pin, Mark Namchuk	50
10	Delivery of long-acting injectable antivirals 2015 ·Current Opinion in Infectious Diseases ·Magali B. Hickey, Elaine Merisko‐Liversidge, Julius F. Remenar, Mark Namchuk	10
11	(S)-1-((S)-2-{[1-(4-Amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2 R,3 S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an Orally Available Selective Interleukin (IL)-Converting Enzyme/Caspase-1 Inhibitor, Exhibits Potent Anti-Inflammatory Activities by Inhibiting the Release of IL-1β and IL-18 2007 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), (unknown), Mark Namchuk, John R. Pollard, Pamella J. Ford, George Ku, Caroline J. Decker, Paul S. Charifson, Peter Weber, Ursula A. Germann, Keisuke Kuida, John C.R. Randle	250
12	c-Jun N-Terminal Kinases Mediate Reactivation of Akt and Cardiomyocyte Survival After Hypoxic Injury In Vitro and In Vivo 2005 ·Circulation Research ·Zhili Shao, Kausik Bhattacharya, Eileen Hsich, Larry Park, Brian Walters, Ursula A. Germann, Yow‐Ming Wang, John Kyriakis, Ramon Mohanlal, Keisuke Kuida, Mark Namchuk, Francesco G. Salituro, Yung‐Mae Yao, Weimin Hou, Xin Chen, Mark Aronovitz, Philip N. Tsichlis, Susmita Bhattacharya, Thomas Force, Heiko Kilter	106
13	Inhibitors of Protein Kinase Signaling Pathways 2004 ·Circulation ·Thomas Force, Keisuke Kuida, Mark Namchuk, Keykavous Parang, John Kyriakis	103
14	Designing screens: how to make your hits a hit 2003 ·Nature Reviews Drug Discovery ·W. Patrick Walters, Mark Namchuk	279
15	Phosphorylation of Serine Residues 3, 6, 10, and 13 Distinguishes Membrane Anchored from Soluble Glutamic Acid Decarboxylase 65 and Is Restricted to Glutamic Acid Decarboxylase 65α 1997 ·Journal of Biological Chemistry ·Mark Namchuk, (unknown), Christoph W. Turck, Jamil Kanaani, Steinunn Bækkeskov	58
16	Substrate-induced inactivation of a crippled .beta.-glucosidase mutant: identification of the labeled amino acid and mutagenic analysis of its role 1995 ·Biochemistry ·John C. Gebler, Donald Trimbur, R. Antony J. Warren, Ruedi Aebersold, Mark Namchuk, Stephen G. Withers	38
17	Mechanism of Agrobacterium .beta.-glucosidase: kinetic analysis of the role of noncovalent enzyme/substrate interactions 1995 ·Biochemistry ·Mark Namchuk, Stephen G. Withers	150
18	Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. 1994 ·The Journal of Experimental Medicine ·John Kim, Mark Namchuk, Teodorica L. Bugawan, Qin Fu, Marc G. Jaffe, Yongmin Shi, Henk‐Jan Aanstoot, Christoph W. Turck, (unknown), Vanda A. Lennon, Steinunn Bækkeskov	148
19	Syntheses of 2-deoxy-2-fluoro mono- and oligo-saccharide glycosides from glycals and evaluation as glycosidase inhibitors 1993 ·Carbohydrate Research ·John D. McCarter, (unknown), Curtis Braun, Mark Namchuk, Dedreia Tull, Stephen G. Withers	48
20	Design, synthesis, and characterization of a protein sequencing reagent yielding amino acid derivatives with enhanced detectability by mass spectrometry 1992 ·Protein Science ·Ruedi Aebersold, Edward J. Bures, (unknown), Mark Namchuk, Bori Shushan, (unknown)	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact